Skip to main content

Table 3 Study variables and assessment points

From: Effectiveness of a transdiagnostic internet-based protocol for the treatment of emotional disorders versus treatment as usual in specialized care: study protocol for a randomized controlled trial

Instrument

Assessment area

Time of assessment

MINI Neuropsychiatric

Psychiatric diagnosis

Baseline, Post-T and follow-ups

Interview

BAI

Severity of anxiety

Baseline, Post-T and follow-ups

BDI-II

Severity of depression

Baseline, Post-T and follow-ups

Sociodemographic data

Gender, age, marital status, education, occupation, economic level

Baseline

OASIS

Severity of anxiety

Post-module

ODSIS

Severity of depression

Post-module

SIAS

Severity of SAD symptoms

Baseline, Post-T and follow-ups

PDSS-SR

Severity of PD and agoraphobia symptoms

Baseline, Post-T and follow-ups

PSWQ

Severity of GAD symptoms

Baseline, Post-T and follow-ups

OCI-R

Severity of OCD symptoms

Baseline, Post-T and follow-ups

EQ-5D

Health-related quality of life

Baseline, Post-T and follow-ups

PANAS

Positive and negative affect

Post-module

BIS-BAS

Behavioral inhibition/activation

Baseline, Post-T and follow-ups

ETS

Expectation of treatment

Baseline

OTS

Opinion of treatment

Post-T

  1. Post-T, post-treatment (18 weeks after baseline); follow-ups, 3- and 12-month follow-ups. BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory-II; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; SIAS, Social Interaction Anxiety Scale; PDSS-SR, Self-Reported Panic Disorder Severity Scale; PSWQ, Penn State Worry Questionnaire; OCI-R, Obsessive-Compulsive Inventory-Revised; EQ-5D, EuroQoL-5D questionnaire PANAS, Positive and Negative Affect Scale; BIS-BAS, Behavioral Inhibition and Behavioral Activation Scales; ETS, Expectation of Treatment Scale; OTS, Opinion of Treatment Scale